Anavex Life Sciences Corp (AVXL)

[frrol]

Like all biotechs, we're highly dependent on third parties, the primary ones being CROs and trial sites. We can't dictate their completion timelines. It's why enrollment and results often take longer than expected. Management included.

Our TLR PR will look like our others. Missling wasn't hiding some fantastical complex analysis of wonderfulness in his previous timeline targets; he was getting timeline updates from our CRO, hence the new targets. It then takes mgmt and the SAB some time to review the CRO's report and compose a public release. (Which finally requires a quick legal review.) There's no fantasy involved. Remember when folks were claiming the PDD 'delay' was because we're probably coordinating the announcement with the MJFF? Or because we're probably getting early approval? It can get pretty silly.